TAG welcomes the news of increased investment from the U.S. government in TB research and development; urges all countries to follow through on commitments made at the 2018 UN High-Level Meeting on TB.

Statement from DR-TB STAT and TAG outlining practice-based recommendations for the optimal management of RR/MDR-TB. 

The section provides an overview of research and development of innovations for diagnosing, preventing, treating TB in children.

Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.

Treatment Action Group (TAG) is seeking a highly motivated and organized TB Project Officer to support TAG’s advocacy portfolio on TB. The deadline for applications is 19 June 2019.

Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.

The guide details important efficacy, safety, and access information on rifapentine, a game-changing drug for treating TB infection in order to prevent active TB disease.

This TAGline is all about the importance of community engagement in research to end the epidemics of HIV, HCV, and TB. As this edition’s cover shows, protestors at the “Storm the NIH” demonstration and die-in in May 1990 demanded political will and funding for research, and equitable access to treatment for HIV. This bold and knowledgeable action brought about a massive increase to investment in HIV research, and extensive changes to how AIDS clinical trials were conducted.

Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test for TB in people living with HIV.

Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate